InvestorsHub Logo
Replies to #81419 on Biotech Values
icon url

apljack

07/26/09 11:19 PM

#81474 RE: DewDiligence #81419

ABT and NGNM:

Ahhhhhhhhh....I'm back from a week-long beach vacation that included a self-imposed blackout from internet information, office related cell phone interruptions (and I personally thank my new secretary for managing to manage things and leave me alone) and even newspapers and watches (left that damn thing in the nightstand). All eschewed for the beach, sun, sand and snorkling!

What great news for my portfolio and NGNM. This gives NGNM the bona fides, from a business standpoint, to be able to garner the attention of both potential partners and competitors that they are a growing force to be reckoned with. The co., already growing at a healthy clip of 40-60% YOY, will likely be able to push revenues to above $100 million by 2011 rather than 2012 as they have previously hinted was their goal, with this new partnership.

More importantly, from my point of view, is that the co is now capable of sitting down with smaller private labs to talk consolidation and merger activity. This co. was built, from the beginning, to grow and become a consolidation target themselves. I suggest that there is value here at least below $4 a share, which will undoubtedly be the next technical threshold for the co. to overcome (along with full listing).

aj